Judge Dismisses Pharmaceutical Manufacturer's $30M Business Interruption Coverage Claims Over Damaged Pfizer Drug
“Mere inability to use a room thus does not amount to direct physical loss of the room. Moreover, the policy expressly excludes ‘[l]oss or damage arising from loss of use.’ This exclusion straightforwardly applies to bar the loss of use claim asserted by AMAG here,” wrote U.S. District Judge Myong J. Joun of the District of Massachusetts.